merged_adhd-life-expectancy.txt
<other>I will now answer each question based on my analysis of the article, making sure to only use information from the article and follow the specified format.</other>
<question_number>1</question_number>
<answer>The 2022 meta-analysis focused on unnatural causes of death, while the British study used all-cause mortality data.</answer>
<question_number>2</question_number>
<answer>If causes of death are unrecorded, focusing solely on identified comorbidities might miss other crucial factors contributing to early mortality, rendering prevention strategies incomplete.</answer>
<question_number>3</question_number>
<answer>N/A</answer>
<question_number>4</question_number>
<answer>The study's caveat about underdiagnosis, alongside rising adult diagnoses in marginalized groups, suggests the study sample might be skewed towards more severe, earlier-diagnosed cases, potentially overestimating mortality risks for the broader A.D.H.D. population including newly diagnosed adults.</answer>
<question_number>5</question_number>
<answer>The Adderall shortage is a recent event and occurred after the study's 2000-2019 observation window, so it is not a confounding variable for the study's mortality calculations.</answer>